· Published by Health Canada · Official notice
This is duplicated text of a letter from Disetronic Medical Systems, Inc.
Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
Disetronic Medical Systems, Inc.
5151 Program Avenue
St. Paul, MN 55112-1014
800-280-7801
763-795-5200
Fax 763-795-5300
http://www.disetronic-usa.com
03-140
August 11, 2003
Canada
Issue
The U.S. Food and Drug Administration (FDA) inspected our insulin infusion pump manufacturing facility and determined that our manufacturing processes are not in substantial compliance with the regulations. In the absence of compliance with these regulations, the reliability of devices cannot be assured, which could potentially result in problems with the product leading to over and/or under infusion of insulin. Based on the evaluation of the observations with Health Canada, we have decided not to ship H-TRON V100 or H-TRONplus V100 insulin pumps to any new customers until we have improved our manufacturing processes to adequately ensure the reliability of our pumps for their intended use. Some of the problems that have been reported include water ingress, cracks in the case, and short-lived batteries. Pumps that do not perform reliably as expected may lead to hypoglycemic or hyperglycemic events, the symptoms of which are described below.
Health Canada has asked that we inform you of this situation. You should discuss this information with your healthcare professional so that you can make an informed decision regarding the continued use of your H-TRON/H-TRONplus pump. After discussing this with your healthcare professional, if you wish to discontinue use of your pump, have your pump replaced, or have questions regarding your pump, please refer to the "Actions" section of this letter.
If you, along with your healthcare professional, decide to continue using your H-TRON/ H-TRONplus pump, we would like to remind you of a previously communicated defect with respect to water exposure. This defect may result in unintended delivery of a bolus. This warning is also included in your pump Reference Manual, in the section entitled "Warnings".
Warning: Avoid any contact of the pump with water. Water entering the pump may result in a malfunction which could cause severe hypoglycemia (low blood glucose value) or complete pump shutdown. Do not use your pump if it has been exposed to water.
Symptoms of Hypoglycemia and Hyperglycemia
Symptoms of hypoglycemia include:
Symptoms of hyperglycemia include:
Precautions
Do not use your pump if it has been exposed to water or if you detect water in the pump casing. If you think the cartridge contents are inconsistent with what you expect based upon visual inspection, then put the pump in STOP immediately and take the following steps:
Actions
Questions
We deeply regret any inconvenience this situation may cause. This notification is being made with the knowledge of Health Canada. Please contact us at 1-866-307-2344 if you have questions about the information contained in this communication.
Any suspected adverse incident can also be reported to:
Health Products & Food Branch Inspectorate
HEALTH CANADA
Address Locator: 3002C
OTTAWA, Ontario, K1A 0K9
Tel: The Medical Devices Hotline 1-800-267-9675